Viewing StudyNCT00307931



Ignite Creation Date: 2024-05-05 @ 4:45 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00307931
Status: TERMINATED
Last Update Posted: 2011-08-31
First Post: 2006-03-24

Brief Title: Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohns Disease Who Failed Infliximab
Sponsor: UCB Pharma
Organization: UCB Pharma

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-04
Start Date Type: None
Primary Completion Date: 2008-08
Primary Completion Date Type: ACTUAL
Completion Date: 2008-08
Completion Date Type: ACTUAL
First Submit Date: 2006-03-24
First Submit QC Date: March 24 2006
Study First Post Date: 2006-03-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2009-10-19
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-08-30
Last Update Post Date: 2011-08-31
Last Update Post Date Type: ESTIMATED